Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
168 studies found for:    "thrombotic thrombocytopenic purpura" OR "Purpura, Thrombocytopenic"
Show Display Options
Rank Status Study
21 Recruiting Early Predictive Factors of Cardiac and Cerebral Involvement in TMA
Conditions: Thrombotic Microangiopathy,;   Thrombotic Thrombocytopenic Purpura,
Intervention: Other: Biological and imaging investigations
22 Completed
Has Results
Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Eltrombopag oral tablets
23 Completed
Has Results
Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
Condition: Purpura, Thrombocytopaenic, Idiopathic
Intervention: Drug: eltrombopag
24 Completed Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Rituximab;   Drug: Placebo
25 Recruiting A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Eltrombopag Tablets;   Drug: Eltrombopag PfOS
26 Completed
Has Results
Pilot Study of be Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Fostamatinib Disodium / R935788
27 Active, not recruiting A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Eltrombopag olamine
28 Completed Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura
Conditions: Idiopathic Thrombocytopenic Purpura;   Immune Thrombocytopenic Purpura
Intervention: Biological: Inactivated Trivalent Influenza vaccine
29 Active, not recruiting Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Autoimmune Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Autoimmune
Intervention: Biological: veltuzumab
30 Completed Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Idiopathic Thrombocytopenic Purpura (ITP);   Immune Thrombocytopenic Purpura (ITP)
Intervention: Drug: rituximab
31 Completed Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients
Conditions: Immune Thrombocytopenic Purpura;   Helicobacter Pylori Infection
Intervention: Drug: H. pylori triple therapy
32 Completed Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)
Condition: Thrombocytopenic Purpura
Intervention: Drug: AMG 531
33 Completed
Has Results
Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10
Condition: Immune Thrombocytopenic Purpura
Intervention: Biological: Immunoglobulin Intravenous (Human)
34 Completed Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: AMG 531
35 Recruiting A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
Condition: Immune Thrombocytopenic Purpura
Interventions: Drug: Fostamatinib Disodium;   Drug: Placebo
36 Completed
Has Results
Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Interventions: Drug: Placebo;   Drug: AMG 531
37 Completed Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura
Condition: Idiopathic Thrombocytopenic Purpura
Intervention:
38 Terminated
Has Results
Initial Treatment of Patients With Immune Thrombocytopenic Purpura
Condition: Immune Thrombocytopenic Purpura
Interventions: Drug: Dexamethasone USP Micronized;   Drug: Prednisone
39 Completed Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Anti-D
40 Recruiting Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: BI 655064

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years